The American Physiological Society Press Release

press release logo

APS Contact: APS Communications Office

Email: communications@the-aps.org

Phone: 301.634.7209

Twitter: @APSPhysiology


New Generation Drugs May Hold Key to Alternative Erectile Dysfunction Treatment

Study finds chloride channel blockers effective in rabbit cell studies

Bethesda, Md. (September 6, 2017)—Close to 70 percent of men with erectile dysfunction (ED) respond to the ED drug sildenafil. However, only about 50 percent of men with diabetes—a population commonly affected by ED—achieve positive results with sildenafil. Researchers from the Smooth Muscle Research Centre at the Dundalk Institute of Technology, in Dundalk, Ireland, are studying two new drugs that may give men with diabetes—and others for whom conventional treatment is ineffective—new hope for treating ED. The article is published ahead of print in the American Journal of Physiology—Cell Physiology.

For a successful erection to occur, the smooth muscle in the erectile tissue (corpus cavernosum) must relax, explained Keith Thornbury, PhD, corresponding author of the study.  However, constant erection is prevented because the tissue contracts. The contraction is controlled by negatively charged chloride moving from inside the cells to outside.  In a chain reaction, the outward flow of chloride causes calcium to flow into the cells. When calcium enters the smooth muscle cells of the erectile tissue, it contracts, preventing erection.

The research team treated cells from the corpus cavernosum of male rabbits with two different chloride channel blocking drugs. They found that both drugs were able to block the flow of chloride, causing the smooth muscle cells to relax. This is a different pathway to treating ED than sildenafil, which hinders the effects of a blood flow-regulating enzyme. “This suggests that chloride channels play an important role in maintaining detumescence [state of non-erection] in the corpus cavernosum and, therefore, might present a future target for treating erectile dysfunction,” the researchers wrote. 

Read the full article, “The role of Ca2+-activated Cl- current in tone generation in the rabbit corpus cavernosum” published ahead of print in the American Journal of Physiology—Cell Physiology.

NOTE TO JOURNALISTS: To schedule an interview with a member of the research team, please contact the APS Communications Office or 301-634-7209. Find more research highlights in the APS Press Room.

Physiology is the study of how molecules, cells, tissues and organs function in health and disease. Established in 1887, the American Physiological Society (APS) was the first U.S. society in the biomedical sciences field. The Society represents more than 10,500 members and publishes 15 peer-reviewed journals with a worldwide readership.

 


RelatedItems

Erectile Dysfunction In Diabetes Is Due To Selective Defect In The Brain

Released March 15, 2007 - A new study sheds additional light on how erectile dysfunction (ED) interacts with diabetes. The study is another step in uncovering the link between the two disorders, and may lead to improved efficacy in treatments.

The “Female Advantage” In Kidney Disease Doesn't Extend To Diabetic Women

Released August 8, 2007 - Women have a “female advantage” when it comes to chronic kidney disease. When compared to men, they have fewer and less severe episodes throughout most of their lives. That advantage disappears, however, when the woman is diabetic. For reasons still unclear, diabetic women are diagnosed with kidney and heart diseases almost as frequently as men. What is it about diabetes that predisposes a woman to develop renal disease at levels generally associated with her male counterpart? Researchers at Georgetown University’s Center for the Study of Sex Differences in Health, Aging and Disease have identified a novel observation to help explain why.

Gender, Coupled With Diabetes, Affects Vascular Disease Development

Released August 15, 2007 - Diabetes is associated with the development of vascular (blood vessel) disease. As we age, vascular disease becomes more common. It has been thought that females may be more susceptible to the earlier development of vascular disease, as vascular changes are observed in females long before any significant development occurs in males. Now, a team of Georgetown University researchers has determined that the vascular activities in diabetic animals vary according to sex. This discovery may eventually have implications for the way males and females are treated medically in the future.

Exercising Harder—and Shorter—Can Help Type 2 Diabetes

Released December 12, 2011 - Regular exercise has proven benefits in preventing and treating type 2 diabetes, but many patients find it tough to meet the American Diabetes Association guidelines of 150 minutes of moderate to vigorous exercise a week. A new study suggests that there could be a better way. In a small proof-of-principle study in eight type 2 diabetes patients, the researchers found that exercising at a very high intensity, but for a mere 30 minutes a week within a 75 minute total time commitment, lowered overall blood sugar concentrations, reduced post-meal blood sugar spikes, and increased skeletal mitochondrial capacity, a marker of metabolic health. The findings suggest that exercising harder, but in a significantly shorter amount of time, could provide benefits similar to longer, but more moderate, activity.

A Human Hormone Blocker is Found to Help Prevent Obesity & Diabetes During Animal Testing

Released January 3, 2008 - A new study finds that a chemical found in the body is capable of promoting weight loss, improving insulin resistance and reversing diabetes in an animal model. The hormone is gastric inhibitory polypeptide (GIP) receptor blockade.

From: 
Email:  
To: 
Email:  
Subject: 
Message:

~/Custom.Templates/PressRelease.aspx